Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹241 Cr₹336 Cr₹279 Cr₹231 Cr₹46 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹241 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹241 Cr
Mar2024₹336 Cr
Mar2023₹279 Cr
Mar2022₹231 Cr
Mar2021₹46 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹241 Cr
-28.28
Mar2024 ₹336 Cr
20.42
Mar2023 ₹279 Cr
20.77
Mar2022 ₹231 Cr
406.94
Mar2021 ₹46 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹108.9 Cr -2.9% -19.1% -64.8% Stock Analytics
ADANI ENTERPRISES ₹279,840.0 Cr -1.1% 7.2% 7% Stock Analytics
REDINGTON ₹21,948.3 Cr 14.3% 3.3% -2.7% Stock Analytics
HONASA CONSUMER ₹9,862.0 Cr -1.3% 9.7% 37.3% Stock Analytics
MMTC ₹9,292.5 Cr 0.7% -4.8% 9.1% Stock Analytics
LLOYDS ENTERPRISES ₹7,808.3 Cr -4.1% -12.1% 16.6% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2.9%

-19.1%

-64.8%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses